FRCA Notes


Tachyphylaxis, Desensitisation and Tolerance


  • Repeated doses of a drug may lead to a change in pharmacological response for the same dose (increase or decrease in response)
  • Tachyphylaxis is an acute decrease in response to repeated doses over a short time period
  • The most common mechanism is the depletion of (neuro)transmitter stores before resynthesis can take place
  • Drugs exhibiting tachyphylaxis:
    • Ephedrine, an indirectly acting sympathomimetic amine owing to depletion of noradrenaline stores
    • GTN
    • Trimetaphan (a non-competitive nicotinic ACh receptor antagonist)

  • Desensitisation is a chronic loss of response over a longer period
  • Mechanisms include:
    • Structural change in receptor morphology
    • Absolute loss of receptor numbers
    • Changes in downstream signalling pathways
  • For example, the loss of β-adrenoreceptors from myocardial cell surfaces in the continued presence of adrenaline and dobutamine

  • Tolerance is the phenomenon whereby larger doses of a substance are required to produce the same pharmacological effect
  • Mechanisms include:
    • Reduction of receptor density
    • Reduction of receptor affinity
  • Examples include:
    • Chronic opioid use/abuse
    • Nitrate infusion - vascular smooth muscle sulfhydryl groups become depleted
      • This can be circumvented by a 'drug holiday' overnight to allow replenishment of the sulfhydryl groups